1,355
Participants
Start Date
July 31, 2003
Primary Completion Date
October 31, 2004
Study Completion Date
October 31, 2004
Solifenacin succinate
oral
Tolterodine
Oral
Minsk
Antwerp
Brussels
Ghent
Middleheim
Brno
Bulovce
České Budějovice
Mělník
Prague
Aalborg
Aarhus
Copenhagen
Glostrup Municipality
Herlev
Kolding
Odense
Angers
Bordeaux
Clermont-Ferrand
Lille
Nantes
Paris
Reims
Rouen
Saint-Priest-en-Jarez
Toulouse
Bad Ems
Emmendingen
Frankfurt
Freiburg im Breisgau
Hagenow
Hamburg
Koblenz
Rheinfelden
Trier
Uetersen
Athens
Larissa
Pátrai
Thessaloniki
Budapest
Nyíregyháza
Szolnok
Tatabánya
Montecchio Emilia
Novara
Orbassano
Rome
Sassari
Sesto San Giovanni
Varese
Verona
Apeldoorn
Ede
Eindhoven
Groningen
Nijmegen
Roermond
Tilburg
Zeist
Bodø
Haugesund
Rud
Tønsberg
Moscow
Saint Petersburg
Bratislava
Košice
Martin
Prešov
Skalica
Alicante
Bilbao
Burgos
Llobregat
Madrid
Santiago de Compostela
Seville
Valencia
Valladolid
Gothenburg
Malmo
Nyköping
Stockholm
Kiev
Birmingham
Harrow
Leicester
Liverpool
London
Plymouth
Sheffield
Stevenage
Swansea
Lead Sponsor
Astellas Pharma Inc
INDUSTRY